Dangas, George D <br/><br/>
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).  [electronic resource] 

 -  JACC. Cardiovascular interventions  Sep 2013 
 - 914-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1876-7605 
<br/><br/><label>Standard No.: </label>10.1016/j.jcin.2013.05.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiovascular Agents--administration & dosage<br/>Coronary Artery Disease--diagnosis<br/>Coronary Restenosis--etiology<br/>Coronary Thrombosis--etiology<br/>Drug-Eluting Stents<br/>Everolimus<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic<br/>Multivariate Analysis<br/>Myocardial Infarction--etiology<br/>Paclitaxel--administration & dosage<br/>Percutaneous Coronary Intervention--adverse effects<br/>Proportional Hazards Models<br/>Prosthesis Design<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Sirolimus--administration & dosage<br/>Time Factors<br/>Treatment Outcome